Myriad Genetics Inc (NASDAQ:MYGN)
| 16.05 Delayed Data As of Sep 29 |  -0.74 / -4.41%Today’s Change | 13.92 Today|||52-Week Range 24.21 | +10.61% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Diaz Paul J President & Chief Executive Officer |  Sale | 8/13/2023 | 51,292 | $17.89 | $917.6K | -9.94% |
Diaz Paul J President & Chief Executive Officer | Sale | 3/24/2023 | 26,997 | $23.72 | $640.4K | -32.38% |
Diaz Paul J President & Chief Executive Officer | Sale | 3/22/2023 | 20,046 | $22.91 | $459.3K | -29.99% |
Diaz Paul J President & Chief Executive Officer | Sale | 3/24/2023 | 18,428 | $23.72 | $437.1K | -32.38% |
Diaz Paul J President & Chief Executive Officer | Sale | 8/13/2023 | 22,943 | $17.89 | $410.5K | -9.94% |
Riggsbee R Bryan Chief Financial Officer | Sale | 3/02/2023 | 15,000 | $22.55 | $338.3K | -29.96% |
Riggsbee R Bryan Chief Financial Officer | Sale | 12/27/2022 | 20,000 | $15.15 | $303.0K | +4.36% |
Lambert Nicole Chief Operating Officer | Sale | 3/02/2023 | 13,184 | $22.74 | $299.8K | -29.96% |
Riggsbee R Bryan Chief Financial Officer | Sale | 2/18/2023 | 11,222 | $19.42 | $217.9K | -11.77% |
Spiegelman Daniel K Director | Sale | 6/02/2023 | 8,638 | $23.01 | $198.8K | -31.54% |
Page of 8